why choose us

First received: August 15, 2025

Clinical Trial: Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Doxorubicin Induced Cardiotoxicity
Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Brief Summary: The goal of this clinical trial is to evaluate the cardioprotective effect of pentoxifylline against doxorubicin-induced cardiotoxicity in breast cancer patients. The main questions it aims to answer are:1. What is the change in ejection fraction (primary outcome) in breast cancer patients receiving pentoxifylline compared to those who do not?2. What are the changes in serum levels of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), and TNF-? (secondary outcomes) in breast cancer patients receiving…

Read more